Search Results - lai+wei

1 Results

Sort By:

Calcineurin Inhibitor-Antibody Conjugates for Targeted Treatment of Th17 Driven Inflammatory Diseases

The National Eye Institute (NEI) seeks research co-development partners and/or licensees for the development of calcineurin inhibitor-antibody conjugates aimed at treating Th17 driven inflammatory diseases. This technology includes calcineurin inhibitor-antibody conjugates designed for the targeted treatment of Th17 driven inflammatory diseases, such...

Published: 6/18/2026 | Updated: 6/16/2026 | Inventor(s): Andrew Dick, Lauren Schewitz Bowers, Robert Nussenblatt, Lai Wei, Igal Gery, Richard Lee

Keywords(s):

Category(s): Application > Therapeutics, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, ResearchProducts > Antibodies, TherapeuticArea > Immunology, TherapeuticArea > Ophthalmology, TherapeuticArea > Neurology